Washington Times: Ebola vaccine studies progress as marketing quells suspicions of modern medicine
“Ebola had just killed thousands of people in Liberia, and the U.S.-backed pitch to sign locals up for a vaccine trial must have seemed like a tough sell: Take part of the very virus that had devastated the region, combine it with a separate, harmless virus, and inject it into volunteers with the hope they develop Ebola antibodies. But some creative marketing, brutal honesty, and good will built up from months of lifesaving humanitarian efforts paid off, with more than 1,500 volunteers now taking part in a vaccine study run out of Redemption Hospital in Monrovia, the capital…” (Howell, 9/7).